D-0303-2021 Class I Ongoing

Recalled by Bryant Ranch Prepack, Inc. Dba BRP Pharmaceuticals — Burbank, CA

FDA drug recall D-0303-2021 was initiated by Bryant Ranch Prepack, Inc. Dba BRP Pharmaceuticals on Jan 27, 2021 and is designated Class I. Reason for recall: Labeling: Label Mix-Up - Prepackaged bottles labeled spironolactone 25 mg may contain spironolactone 50 mg tablets. The recall status is ongoing. Affected quantity: 35 bottles.

Recall details

Product Type
Drugs
Report Date
Mar 24, 2021
Initiation Date
Jan 27, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
35 bottles

Product description

Spironolactone Tablets, USP, 25 mg, packaged in: a) 30-count bottles (NDC 63629-1064-01), b) 60-count bottles (NDC 63629-1064-02), c) 90-count bottles (NDC 63629-1064-03), Rx only, Manufactured by: Frontida BioPharm, Inc., Philadelphia, PA 19124 USA, Repackaged by: Bryant Ranch Prepack, Inc., Burbank, CA 91504 USA

Reason for recall

Labeling: Label Mix-Up - Prepackaged bottles labeled spironolactone 25 mg may contain spironolactone 50 mg tablets.

Distribution pattern

Nationwide in the USA

Code information

a) Lot #: 148969, Exp 7/31/2022, b) Lot #: 148791, Exp 7/31/2022, c) Lot #: 148991, Exp 7/31/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0303-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0303-2021. Report a data issue: hello@regdatalab.com.